Financial Performance - For the three months ended December 31, 2022, the revenue was HK$9,221,000, a decrease of 19.2% compared to HK$11,399,000 for the same period in 2021[12]. - The gross profit for the nine months ended December 31, 2022, was HK$10,105,000, down 35.5% from HK$15,703,000 in the previous year[12]. - The loss for the period for the nine months ended December 31, 2022, was HK$16,330,000, compared to a loss of HK$10,075,000 for the same period in 2021, representing a 62.0% increase in losses[12]. - The basic and diluted loss per share for the nine months ended December 31, 2022, was HK$2.04, compared to HK$1.26 for the same period in 2021, indicating a 62.9% increase in loss per share[12]. - For the nine months ended December 31, 2022, total revenue was HK$30,575,000, down 18.0% from HK$37,253,000 for the same period in 2021[28]. - Total comprehensive income for the period ended December 31, 2022, was a loss of HK$16,330,000, compared to a loss of HK$10,075,000 for the same period in 2021[28]. - The Group incurred a net loss of approximately HK$16.3 million for the nine months ended December 31, 2022, compared to a net loss of approximately HK$10.1 million for the same period in 2021[64]. Revenue Breakdown - Revenue from sales of biometrics identification devices and security products was HK$5,737,000, down 17.0% from HK$6,915,000 in the previous year[28]. - Revenue from the provision of auxiliary and other services decreased to HK$3,484,000, a decline of 22.3% from HK$4,484,000 in the prior year[28]. - The company recognized HK$6,813,000 in revenue at a point in time and HK$2,408,000 recognized over time for the three months ended December 31, 2022[28]. - Sales of biometrics identification devices, security products, and other accessories decreased by approximately HK$4.9 million (or 20.0%) compared to the corresponding period in 2021[55]. Expenses and Costs - Selling and distribution costs for the three months ended December 31, 2022, were HK$2,111,000, a decrease of 8.9% from HK$2,316,000 in the same period of 2021[12]. - Administrative and other operating expenses for the nine months ended December 31, 2022, increased to HK$21,707,000 from HK$19,985,000 in 2021, reflecting an increase of 8.6%[12]. - Staff costs for the three months ended December 31, 2022, amounted to HK$7,380,000, a decrease of 12% from HK$8,403,000 in the same period of 2021[43]. - The cost of inventories sold for the three months ended December 31, 2022, was HK$1,546,000, down 54% from HK$3,403,000 in the same period of 2021[43]. - The Group's costs of inventories sold decreased by approximately 30.5% to approximately HK$8.6 million for the nine months ended December 31, 2022[61]. Corporate Governance - The directors confirmed that the information contained in the report is accurate and complete in all material respects, ensuring transparency for investors[4]. - The Company has maintained compliance with the Corporate Governance Code since listing, with a noted deviation regarding the roles of chairman and CEO being held by the same individual[96][101]. - The Company has established an Audit Committee comprising three independent non-executive Directors to oversee financial reporting and internal control systems[104]. - The Company is committed to high standards of corporate governance to enhance public accountability and safeguard shareholder interests[95]. Future Plans and Market Trends - The Group plans to reallocate part of the unutilized net proceeds from the Listing to enhance after-sales services, improve the IT system, and for working capital[72]. - The Group aims to focus on research and development of touchless biometrics identification devices and AIoT applications in response to changing market trends due to COVID-19[73]. - The company has decided to suspend the launch of locally manufactured affordable fingerprint recognition devices due to declining market demand and COVID-19 uncertainties[74]. - The shift in market trend from contact-based to non-contact biometric devices is being observed due to increased public health awareness during the COVID-19 pandemic[75]. Shareholding and Securities - As of December 31, 2022, Mr. Tony Yuen and Ms. Pauline Yuen each hold 206,000,000 shares, representing 25.75% of the company's issued share capital[79]. - Mr. Yao Han and Ms. Jian Yanmei each hold 190,000,000 shares, representing 23.75% of the company's issued share capital[84]. - No dividends were declared or paid during the three and nine months ended December 31, 2022, consistent with the same periods in 2021[45]. - The weighted average number of ordinary shares for calculating basic loss per share remained at 800,000,000 for both the three and nine months ended December 31, 2022, and 2021[48]. - No purchases, sales, or redemptions of the company's listed securities occurred during the nine months ended December 31, 2022[87]. Compliance and Audit - The Audit Committee reviewed the unaudited condensed consolidated financial statements for the nine months ended December 31, 2022, and confirmed compliance with applicable accounting standards and GEM Listing Rules[105]. - The Company has ensured adequate disclosure in its financial reporting as per legal requirements[105]. - The Company has not identified any non-compliance with the Model Code from the date of listing to the report date[94].
懒猪科技(08379) - 2023 Q3 - 季度财报